Effect of pramipexole in the treatment of Parkinson after stroke
10.3969/j.issn.1005-1678.2016.11.024
- VernacularTitle:盐酸普拉克索对脑卒中后帕金森病患者的临床疗效
- Author:
Jun XIE
;
Yukui YAN
;
Haiyan TANG
;
Fengxiang HE
- Keywords:
pramipexole;
ischemic stroke;
Parkinson;
inflammatory factor;
oxidative stress
- From:
Chinese Journal of Biochemical Pharmaceutics
2016;36(11):84-87
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of pramipexole in the treatment of Parkinson after stroke .Methods 94 cases with Parkinson after stroke in our hospital from June 2013 to November 2015 were randomly selected and divided into two groups,47 cases respectively.Control group received routine etiological and symptomatic treatment, the study group received conventional therapy and symptomatic treatment and pramipexole treatment,two groups were treated for eight weeks.Parkinson’s disease scores,inflammatory cytokines and oxidative stress index,and the clinical effect and complications of contrast were compared after the treatment.Results Compared with before treatment,scores of daily activities of emotion integral integral,the motor function in two groups decreased,levels of serum IL-1β,IL-6,TNF-αand Hs-CRP decreased,levels of CAT,T-SOD,T-GSH in plasma increased (P<0.05),and compared with the control group,scores of daily activities of emotion integral integral,the motor function in the study group were lower,levels of serum IL-1β,IL-6,TNF-αand Hs-CRP were lower,levels of CAT,T-SOD,T-GSH in plasma were higher (P<0.05),and the total effective rate in the study group 91.49% was higher than the control group 74.47% (P<0.05).Conclusion Pramipexole in the treatment of Parkinson after stroke was effective with high safety,and it can reduce Inflammatory factors and increase oxidative stress.
